Cardiovascular and respiratory actions of U50,488H in the unanaesthetized ovine foetus

European Journal of Pharmacology

Volumn 297, Issue 1-2, 1996, Pages 77-82

  Szeto, Hazel H ^a   Wu, Dunli ^a   Cheng, Peter Y ^a   Soong, Yi ^a   Taylor, Cindy C ^a   Yee, Jenny ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Blood pressure; Heart rate; Opioid; Pregnancy; Opioid receptor agonist

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ANALGESIC AGENT; KAPPA OPIATE RECEPTOR AGONIST; NALOXONE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; FEMALE; FETUS; FETUS BREATHING; FETUS CIRCULATION; FETUS HEART RATE; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; RESPIRATION DEPRESSION; SHEEP; TACHYCARDIA;

EID: 0030041806     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00726-1     Document Type: Article

References (31)

1. 3H]U69593 labelled kappa opioid binding sites in the rat spinal cord, Brain Res. 502, 149.
2. Barr, G.A., D.Y. Miya and W. Paredes, 1992, Analgesic effects of intraventricular and intrathecal injection of morphine and ketocyclazocine in the infant rat, Brain Res. 584, 83.
3. Bero, L.A., S.N. Lurie and C.M. Kuhn, 1987, Early ontogeny of kappa-opioid receptor regulation of prolactin secretion in the rat, Brain Res. 465, 189.
4. Boddy, K., G.S. Dawes, R. Fisher, S. Pinter and J.S. Robinson, 1974, Foetal respiratory movements, electrocortical and cardiovascular responses to hypoxia and hypercapnia in sheep, J. Physiol. 243, 599.
5. 2 analysis on the respiratory depressant effects of alfentanil, etonitrazene, ethylketocyclazocine (EKC) and Mr2033 in rhesus monkeys, J. Pharmacol. Exp. Ther. 264, 145.
6. Carter, D.A. and S.L. Lightman, 1985, Selective cardiovascular and neuroendocrine effects of a κ-opioid agonist in the nucleus tractus solitarii of rats, J. Physiol. 367, 363.
7. Castillo, R., I. Kissin and E.L. Bradley, 1986, Selective kappa opioid agonist for spinal analgesia without the risk of respiratory depression, Anesth. Analg. 350, 354.
8. Dawes, G.S., H.E. Fox, M.B. Leduc, G.C. Liggins and R.T. Richards, 1972, Respiratory movements and rapid eye movement sleep in the fetal lamb, J. Physiol. 220, 119.
9. Dosaka-Akita, K., F.C. Tortella, J.W. Holaday and J.B. Long, 1993, The kappa opioid agonist U-50,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious rats, J. Pharmacol. Exp. Ther. 264, 631.
10. Douglas, A.J., G. Clarke, S.J.A. MacMillan, P.M. Bull, I. Neumann, S.A. Way, D.M. Wright, B.G. McGrory and J.A. Russell, 1993, Effects of the kappa-opioid agonist U50,488 on parturition in rats, Br. J. Pharmacol. 109, 251.
11. France, C.P., F. Medzihradsky and J.H. Woods, 1994, Comparison of kappa opioids in rhesus monkeys: behavioral effects and receptor binding affinities, J. Pharmacol. Exp. Ther. 268, 47.
12. Freye, E., E. Hartung and G.K. Schenk, 1983, Bremazocine: an opiate that induces sedation and analgesia without respiratory depression, Anesth. Analg. 62, 483.
13. Hall, E.D., D.L. Wolf and R.B. McCall, 1988, Cardiovascular depressant effects of the kappa opioid receptor agonists U50488H and spiradoline mesylate, Circ. Res. 26, 409.
14. Hayes, A.G., P.P. Birch and E. Cavicchini, 1988, Evidence that the kappa agonist U50488H has nonopioid actions, J. Pharm. Pharmacol. 40, 718.
15. Horan, P., J. Taylor, H.I. Yamamura and F. Porreca, 1992, Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test, J. Pharmacol. Exp. Ther. 260, 1237.
16. Howell, L.L., J. Bergman and W.H. Morse, 1990, Effects of levorphanol and several kappa-selective opioids on respiration and behavior in rhesus monkeys, J. Pharmacol. Exp. Ther. 254, 786.
17. Joubert, D.M. 1956, A study of pre-natal growth and development in sheep, J. Agricol. Sci. 47, 382.
18. May, C.N., M.R. Dashwood, C.J. Whitehead and C.J. Mathias, 1989, Differential cardiovascular and respiratory responses to central administration of selective opioid agonists in conscious rabbits: correlation with receptor distribution, Br. J. Pharmacol. 98, 903.
19. Medina, V.M., L. Wang and A.R. Gintzler, 1993, Spinal cord dynorphin: positive region-specific modulation during pregnancy and parturition, Brain Res. 623, 41.
20. Petrillo, P., A. Tavani, D. Verotta, L.E. Robson and H.W. Kosterlitz, 1987, Differential postnatal development of mu-, delta- and kappa-opioid binding sites in rat brain, Brain Res. 428, 53.
21. Pugsley, M.K., W.P. Penz, M.J.A. Walker and T.M. Wong, 1992, Cardiovascular actions of the κ-agonist, U50,488H, in the absence and presence of opioid receptor blockade, Br. J. Pharmacol. 105, 521.
22. Rimoy, G.H., D.M. Wright, N.K. Bhaskar and P.C. Rubin, 1994, The cardiovascular and central nervous system effects in the human of U-62066E. A selective opioid receptor agonist, Eur. J. Clin. Pharmacol. 46, 203.
23. Sander, H.W. and A.R. Gintzler, 1987, Spinal cord mediation of the opioid analgesia of pregnancy, Brain Res. 408, 389.
24. Sander, H.W., P.S. Portoghese and A.R. Gintzler, 1988, Spinal κ-opiate receptor involvement in the analgesia of pregnancy: effects of intrathecal nor-binaltorphimine, a κ-selective antagonist, Brain Res. 474, 343.
25. Sander, H.W., R.M. Kream and A.R. Gintzler, 1989, Spinal dynorphin involvement in the analgesia of pregnancy: effects of intrathecal dynorphin antisera, Eur. J. Pharmacol. 159, 205.
26. Spanagel, R., O.F.X. Almeida and T.S. Shippenberg, 1994, Evidence that nor-binaltorphimine can function as an antagonist at multiple opioid receptor subtypes, Eur. J. Pharmacol. 264, 157.
27. Szeto, H.H., 1983, Effects of narcotic drugs on fetal behavioral activity: acute methadone exposure, Am. J. Obstet. Gynecol. 146, 211.
28. Szeto, H.H., P.Y. Cheng, Y. Soong and D.L. Wu, 1995, Lack of relationship between opioid-induced changes in fetal breathing and plasma glucose levels, Am. J. Physiol. 269, R702.
29. Von Voigtlander, P.F., R.A. Lahti and J.H. Ludens, 1983, U50,488H: a selective and structurally novel non-mu (kappa) opioid agonist, J. Pharmacol. Exp. Ther. 224, 7.
30. Wollemann, M., S. Benyhe and J. Simon, 1993, The kappa-opioid receptor: Evidence for the different subtypes, Life Sci. 52, 599.
31. Young, A.M., K.R. Stephens, D.W. Hein and J.H. Woods, 1984, Reinforcing and discriminative stimulus properties of mixed agonist-antagonist opioids, J. Pharmacol. Exp. Ther. 229, 118.